Skip to content

Clinical trials

Completed Phase 1 Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 1 Status: Completed Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20053
20063
20073
20081
20094
20104
20114
20121
20131
20142
20152
20161
20172
20182
20193
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Biogen2
Eli Lilly and Company2
GlaxoSmithKline2
Massachusetts General Hospital2
Pfizer2
Sandoz2
Yale University2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder43
Schizophrenia11
Major Depressive Disorder7
Psychotic Disorders6
Depressive Disorder3
Epilepsy2
Stress Disorders, Post-Traumatic2
Alcoholism1
Anxiety Disorders1
Generalized Anxiety Disorder1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.